USFDA completes inspection of J B Chemicals Panoli facility with two observations Medical Dialogues Bureau15 May 2018 10:25 AM ISTNew Delhi: J B Chemicals and Pharmaceuticals said the US health regulator has completed inspection of its Panoli facility in Gujarat with two minor...
Takeda sees lower annual profit, generics to erode cancer drug sales Medical Dialogues Bureau15 May 2018 9:30 AM ISTTOKYO: Japan's Takeda Pharmaceutical Co Ltd on Monday forecast a 17 percent drop in operating profit for the year through March 2019 as blood cancer...
DoJ investigates Mylan on trade compliance for certain products Medical Dialogues Bureau15 May 2018 9:15 AM ISTPharmaceuticals company Mylan NV said that one of its subsidiary received a civil investigative demand from the U.S. Department of Justice regarding...
Aurobindo Pharma's arm recalls 2 antibiotic injections from US Medical Dialogues Bureau14 May 2018 2:12 PM ISTAuro Medics Pharma LLC, a US subsidiary of Aurobindo Pharma Ltd,has initiated voluntary recall of two lots each of two injections from the US market...
China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firms Medical Dialogues Bureau14 May 2018 2:11 PM ISTChina's much-publicised announcement to slash tariffs on 28 medicines, including cancer drugs from India, has failed to create any buzz among the...
Affordable solutions needed to intensify innovations in Indian pharma sector: DGHS Medical Dialogues Bureau13 May 2018 11:57 AM ISTNew Delhi: Advanced, affordable and accessible solutions is the only way forward towards intensifying the innovations in Indian pharma sector,...
Novartis India appoints Milan Paleja as vice chairman and MD Medical Dialogues Bureau13 May 2018 9:52 AM IST New Delhi: Drug firm Novartis India today announced the appointment of Milan Paleja as vice chairman and managing director, with effect from June...
Lupin, its JV submit new drug application for Etanercept biosimilar in Japan Medical Dialogues Bureau13 May 2018 9:12 AM ISTNew Delhi: Drug firm Lupin today said its Japanese arm and YL Biologics have submitted a new drug application (NDA) with the Japanese health regulator...
Indian IP and liabilities law barrier to pharma RnD investment Medical Dialogues Bureau13 May 2018 9:06 AM ISTBOSTON: India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, especially from the US, that...
ASSOCHAM urges greater utilisation of technology in pharmaceuticals Medical Dialogues Bureau13 May 2018 9:00 AM ISTNew Delhi: Advanced, affordable and accessible solutions are the only way forward towards intensifying the innovations in the Indian pharmaceutical...
Zydus Cadila gets USFDA nod for Carbidopa tablets Medical Dialogues Bureau12 May 2018 12:06 PM ISTZydus Cadila has received final approval from the US health regulator to market Carbidopa tablets, used for treating symptoms of Parkinson's disease....
FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients Medical Dialogues Bureau12 May 2018 12:00 PM ISTThe U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age...
